首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy
【24h】

Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy

机译:泌尿道尿路上皮癌患者淋巴血管入侵和肿瘤成果之间的关系

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose To determine the association between lymphovascular invasion (LVI) and upper tract urothelial carcinoma (UTUC) among patients who underwent radical nephroureterectomy (RNU). Materials and methods From 2003 and 2018, retrospective data of 453 patients treated for UTUC with open, laparoscopic, or robotic RNU were collected. Pathological specimens were assessed for LVI through hematoxylin and eosin staining. According to presence of LVI, patients were stratified into two groups and compared for perioperative characteristics. Kaplan-Meier analysis was used to assess progression-free (PFS), cancer-specific (CSS), and overall survival (OS). Uni- and multivariate Cox regression models were used to find significance of LVI to survival. Results LVI was present in 132 (29.1%) of patients and was associated with higher age and lower preoperative GFR. Pathological outcomes included significantly higher tumor grade, higher rates of lymph node invasion and more positive surgical margins. During median 23.2 months follow-up (mean 37.1 months), 59.2% (n = 268) of total patients had tumor recurrence, with highest incidences in lymph nodes (51.5%). 5-year PFS, CSS, and OS were estimated at 35.4%, 94.6%, and 91.1% in LVI-negative patients and 17.2%, 75.1%, and 70.8% in LVI-positive patients, respectively (all p < 0.001). Multivariate analysis showed LVI to be an independent predictor of PFS (HR = 1.480; p = 0.018). Conclusion LVI is an independent predictor of adverse PFS and is associated with poor CSS and OS in patients undergoing RNU for UTUC. These results may guide clinicians in selecting patients for adjuvant chemotherapy. Future prospective trials are necessary to further validate our results.
机译:目的以确定淋巴血管侵袭(LVI)和上部尿路上皮癌(utuc)在接受根治性肾的患者(RNU)的患者之间的关联。收集了2003年和2018年的材料和方法,收集了453例具有开放,腹腔镜或机器人RNU治疗的453名患者的回顾性数据。通过苏木精和曙红染色评估病理标本。根据LVI的存在,患者分层分为两组并比较围手术期特征。 Kaplan-Meier分析用于评估无进展(PFS),癌症特异性(CSS)和总体存活(OS)。 UNI-和多变量COX回归模型用于发现LVI生存的重要性。结果LVI存在于132名(29.1%)的患者中,与较高年龄和更低的术前GFR相关。病理结果包括明显高的肿瘤级,淋巴结侵袭率高,较高的外科余量。在中位数23.2个月期间,总患者的59.2%(n = 268)患者的肿瘤复发,淋巴结最高的发病率(51.5%)。 5年的PFS,CSS和OS估计为35.4%,94.6%和91.1%,分别为17.2%,75.1%,7.2%,75.1%和70.8%(所有P <0.001)。多变量分析显示LVI是PFS的独立预测因子(HR = 1.480; P = 0.018)。结论LVI是不良PFS的独立预测因子,并与UTUC的RNU患者中的CSS和OS相关。这些结果可以指导临床医生选择患者辅助化疗。未来的前瞻性试验是必要的,以进一步验证我们的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号